More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-22 of 22 results

  • www.alnylam.ca
  • 2
  • 3
Alnylam is the leading RNAi therapeutics company. We are a U.S.-based biopharmaceutical company with operations around the world. Founded in 2002 on a bold vision to turn Nobel Prize-winning science into an entirely new class of medicines, Alnylam..
Relevance: 126.73756
  • www.etherapeutics.co.uk
  • 3
  • 1
  • 6
e-therapeutics is integrating computational power and biology to accelerate the discovery of life-transforming RNAi medicines... Working at e-therapeutics offers the opportunity to make a difference by discovering life-transforming RNAi medicines in..
Relevance: 58.161835
  • www.triphosthera.com
  • 1
  • 1
  • 5
Triphos Therapeutics is focused on the optimization of this platform delivery technology, as well as advancement of its own therapeutic programs for the treatment of genetic diseases... Triphos Therapeutics, Inc. is a biopharmaceutical company..
Relevance: 56.094696
  • news.alnylam.com
  • 1
  • 2
It's not every day that a groundbreaking scientific discovery leads to a potential new class of medicines. But that's exactly what's happening at Alnylam. From the "Eureka!" moment of discovering RNA interference (RNAi) to the clinical progress and..
Relevance: 55.42626
  • www.sirnagen.com
  • 1
  • 3
At siRNAgen Therapeutics, we believe in a future where patients with immunology and CNS conditions can live healthier longer lives. Using a versatile double conjugate micellar RNAi platform called SAMiRNA, siRNAgen is developing an active pipeline of..
Relevance: 53.90816
  • www.sanegenebio.com
  • 1
  • 6
SanegeneBio is an emerging RNAi-based company developing innovative RNA interference (RNAi) therapeutics driven by the cutting-edge delivery technology. Founded in 2021, SanegeneBio was propelled by a team of industry-leading experts and has..
Relevance: 53.77037
  • www.acevirt.com
  • 1
Pharma company (PC) is a biopharmaceutical company leveraging an outstanding level of knowledge and experience in RNA interference (RNAi) technology to forge a path to high value creation through discovery and development of therapeutics for human..
Relevance: 49.740295
  • sirnatransfection.org
Welcome to siRNA transfection resource. In biomedical applications, this process of RNA interference has encouraged researchers to study ways in which this process can be utilized to shut down or effectively incapacitate a defective or non-wanted..
Relevance: 47.161545
  • www.virocan.com
  • 2
Virocan Therapeutics Pvt. Ltd (Virocan) is a privately held biotech drug discovery company with expertise in cancer, obesity and cardiovascular diseases. Our strength is to connect various cutting edge discoveries in the field of RNA interference..
Relevance: 46.354218
  • micurerx.com
  • 1
  • 2
  • 11
Originally founded in 2013 with technology spun out of the Weizmann Institute of Science, miCure leverages its deep understanding of the role of microRNAs in the biology of psychiatric diseases. More recently, the company has expanded its scientific..
Relevance: 43.404285
  • oligon.com
  • 3
  • 15
We aim to change the clinical status quo by pioneering a new approach to treating complex diseases. Disrupting industries takes tremendous grit, commitment, and courage so we believe in a culture that seeks excellence... We combine the potent..
Relevance: 41.811188
  • www.vitarka.co.uk
  • 1
We are an experienced leadership team with proven excellence in big pharma drug development including project management, study design, lead identification, optimization and clinical development... We workd with a strong strategic network alliance..
Relevance: 39.684856
  • www.speratum.com
  • 1
  • 14
Speratum is a pre-clinical stage biotechnology company focused on research and development of targeted molecular therapeutics based on core technologies exclusively licensed from Baylor College of Medicine. Speratum's platforms for drug delivery and..
Relevance: 38.493263
  • www.cenix-bioscience.com
  • 1
  • 1
Cenix BioScience is a contract research organization focused on the discovery and pre-clinical development of novel therapeutics, specializing in advanced applications of RNA interference (RNAi) gene silencing combined with high content phenotyping..
Relevance: 35.338017
  • www.alnylam.com
  • 6
  • 8
  • 24
At Alnylam, we are inspired by the perseverance of our patients, committed to our employees, and focused on making a difference in the geographic and disease areas in which we work... AL-NY-LAM. Our name may not be the easiest to pronounce, but once..
Relevance: 32.289177
  • www.curigin.com
  • 1
  • 1
  • 5
Curigin is a company focused on the development of new drugs with a sincere passion for research and development. After developing an adenoviral vector capable of delivering bispecific RNAi in 2018, more than 5 types of vectors and 15 pipelines have..
Relevance: 29.230013
  • dowdylab.ucsd.edu
  • 1
  • 3
  • 6
Our lab is focused on the development of targeted delivery of RNAi and ASO therapeutics. We pioneered the synthesis of bioreversible, charge neutral phosphotriester-backbone modifications, called short interfering RiboNucleic Neutrals (siRNNs). We..
Relevance: 26.789175
  • vasrx.com
  • 2
VasoRx is leading the translation of technologies discovered at M.I.T. and Yale for the delivery of RNAs for the treatment of diseases. With the first approved RNAi therapeutic in the U.S., the field of RNA medicines is rapidly expanding. Delivery of..
Relevance: 20.653107
  • cellecta.com
  • 6
  • 1
Cellecta is headed by an experienced management and product development team with an excellent product development track record, a network of outside scientific collaborators, and prior experience in start-up company operations. Located in Mountain..
Relevance: 16.286253
  • www.nano4glio.org
  • 2
  • 1
The main objective of this project is to establish a new therapeutic approach for cancer treatment in general and for glioblastoma (GBM) in particular, a tumor for which there is no effective treatment. Novelty of the project relies not only on the..
Relevance: 15.524055
  • bianoscience.com
  • 1
With more than 15 years of experience in RNA interference BianoGMP is more than an oligo supplier - it is a partner for your projects... BianoScience was founded as a Spin-off from the Friedrich-Schiller-University of Jena, Germany, in 2011 as a..
Relevance: 13.5784
  • www.thecyclingscientist.com
  • 1
  • 1
Alzheimer's disease (AD) is a complex multifactorial disorder with poorly characterized pathogenesis. Our understanding of this disease would thus benefit from an approach that addresses this complexity by elucidating the regulatory networks that are..
Relevance: 5.5829053